drugset / Trial / NCT04412395
Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
Phase 2
Unknown
516 enrolled
National Research Centre, Egypt
Egyptian Military Medical Services · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the study is to clinically use bovine Lf as a safe antiviral adjuvant for treatment and to assess the potential in reducing mortality and morbidity rates in COVID-19 patients. The study was approved by the ethical committee of the Egyptian Center for Research and Regenerative Medicine in 11-5-2020.
Timeline
- Start
- 2022-02-01
- Primary completion
- 2022-08-01
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactoferrin | Protein / enzyme biologic | 1200 mg | Oral |